Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

102.39 +0.52 (+0.51%)
Streaming Delayed Price Updated: 3:33 PM EDT, Mar 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,861,296
Open 102.54
Bid (Size) 102.38 (100)
Ask (Size) 102.41 (200)
Prev. Close 101.88
Today's Range 100.88 - 103.68
52wk Range 101.82 - 139.06
Shares Outstanding 1,750,942,289
Dividend Yield 2.46%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Deep Dive: Boston Scientific (BSX) and the New Era of Medical Device Dominance
Date: March 31, 2026 Introduction Boston Scientific Corporation (NYSE: BSX) finds itself at a critical crossroads this morning. After a year of record-breaking growth and the successful launch of its... 
Via Finterra
Topics Lawsuit Product Recall
News headline image
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks ↗
The Schwab U.S. Dividend Equity ETF is increasing its allocation to healthcare dividend stocks. 
Via The Motley Fool
Topics ETFs Stocks

Performance

YTD
-17.5%
-17.5%
1 Month
-10.3%
-10.3%
3 Month
-17.8%
-17.8%
6 Month
-23.1%
-23.1%
1 Year
-22.8%
-22.8%

More News

Read More
Abbott Laboratories (NYSE:ABT) Passes the 'Caviar Cruise' Quality Investing Screen ↗
Via Chartmill
News headline image
The Great Divergence: Q1 2026 M&A Hits Record $813.3 Billion Amidst "K-Shaped" Recovery
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics
Via MarketMinute
Topics Supply Chain
News headline image
2 Defensive Healthcare Stocks to Buy Right Now ↗
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
The Record-Breaking M&A Renaissance of 2026: Why Deal Values are Soaring as Volume Dips
Via MarketMinute
Topics Artificial Intelligence Economy Workforce
Abbott Laboratories (NYSE:ABT) Emerges as a Top Dividend Stock with Strong Fundamentals ↗
Via Chartmill
News headline image
1 Magnificent Dividend Stock Down 22% That's a Screaming Buy Right Now ↗
Via The Motley Fool
News headline image
The Best Dividend Stocks to Buy and Hold Forever ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
Via StockStory
News headline image
Macroeconomic Headwinds and Shifting Demand Force Healthcare Giants to Trim 2026 Outlooks
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
2 Profitable Stocks on Our Watchlist and 1 We Avoid
Via StockStory
News headline image
The Return of the Titans: M&A Volume Set to Surge 20% in 2026 Amidst "Animal Spirits"
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
2 Reasons to Like ABT and 1 to Stay Skeptical
Via StockStory
Topics Stocks Supply Chain
News headline image
Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time ↗
Via The Motley Fool
Topics Cannabis Initial Public Offering
News headline image
The Great Unlocking: Medtronic’s Strategic Pivot and the MiniMed Spin-Off
Via Finterra
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Abbott Labs: A Boring Dividend Machine That Could Quietly Make You Rich ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Medtronic Hits 10-Quarter High: PFA Dominance and Robotic Surges Signal a New Era for MedTech
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape
Via MarketMinute
News headline image
Medtronic Hits Ten-Quarter Growth Peak in Q3 Fiscal 2026, Signaling Resurgence in MedTech Sector
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
3 Large-Cap Stocks with Solid Fundamentals
Via StockStory
News headline image
Insulet (PODD) Shakes the Market with Q4 Earnings Beat as Omnipod 5 Dominance Continues
Via MarketMinute
Topics Earnings
News headline image
Medtronic (MDT): The Sleeping Giant Awakes with Strong Q3 FY26 Momentum
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 We Turn Down
Via StockStory

Frequently Asked Questions

Is Abbott Laboratories publicly traded?
Yes, Abbott Laboratories is publicly traded.
What exchange does Abbott Laboratories trade on?
Abbott Laboratories trades on the New York Stock Exchange
What is the ticker symbol for Abbott Laboratories?
The ticker symbol for Abbott Laboratories is ABT on the New York Stock Exchange
What is the current price of Abbott Laboratories?
The current price of Abbott Laboratories is 102.39
When was Abbott Laboratories last traded?
The last trade of Abbott Laboratories was at 03/31/26 03:33 PM ET
What is the market capitalization of Abbott Laboratories?
The market capitalization of Abbott Laboratories is 179.29B
How many shares of Abbott Laboratories are outstanding?
Abbott Laboratories has 179B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.